BioMarin Pharmaceutical Inc. (NASDAQ:
BMRN) shares spiked 7.7% to $104.30 after Sarepta reported the USPTO decision in patent interference case with BioMarin. Share volume totaled 1.7 million, compared to an all-day average of 1.3 million
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
